Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerResearch Summary
Analyzed using Evidence Intelligence™
Post-meal walking may improve glycemic control in type 2 diabetes
Last updated August 16, 2026
Key finding
HbA1c was reduced by -0.05% in post-meal walking group.
This study examined the effects of post-meal walking versus prandial insulin on glycemic control in type 2 diabetic patients, finding no significant differences in outcomes.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Extended (5–20+ y)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study examined the effects of post-meal walking versus prandial insulin on glycemic control in type 2 diabetic patients, finding no significant differences in outcomes.
Clinical relevance
Understanding effective strategies for managing blood sugar is crucial for diabetes care. This study highlights that both post-meal walking and prandial insulin may not lead to significant improvements in glycemic control, prompting further investigation into alternative management strategies for type 2 diabetes.
Keep in mind
Limited sample size may affect generalizability Short duration of the study may not capture long-term effects No significant differences may indicate a need for more sensitive measures
Published in
Journal Reference
Publication details and source links for this paper.
Onnicha S, Chatvara A, Sunee S, Atiporn I, Chatchalit R, Noël CB. The effect of post-meal walking on glycemic control compared with prandial insulin in type 2 diabetic patients. PLOS ONE. 2020;15(4):e0230554. doi:10.1371/journal.pone.0230554
Main Effects
No significant difference in HbA1c reduction with post-meal walking (-0.05%)
No significant difference in HbA1c reduction with prandial insulin (-0.19%)
No significant difference in fructosamine reduction with post-meal walking (-17.5 μmol/L)
No significant difference in fructosamine reduction with prandial insulin (-10 μmol/L)
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Basal insulin, Post-meal walking and Fructosamine, HbA1c.
This study contributes evidence to
Primary intervention
Basal insulin
Primary outcomes
- Fructosamine
- HbA1c
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
4
Evidence pairs
4
Relationships
2
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 64
2
Related topics
4
Evidence pairs
371
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 4 evidence relationships
- Includes primary outcome data
- Linked to 2 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Add related evidence to your Evidence Tracker
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Insulin Therapies and HbA1c
Related evidence
Evidence topic
HbA1c Reduction
Save evidence
Evidence topic
Insulin Therapies
Save evidence
Core evidence
Study findings
The primary outcomes reported in this study.
Evidence Intelligence™
- EvidenceScore™
- 79
- Strong
- ImpactScore™
- 58
- Slightly Positive
- ConsistencyScore™
- 67
- generally_consistent
Supporting studies: Based on 3 studies
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Suggest
- Post-meal walking showed a -0.05% change in HbA1c with no significant difference.
- Prandial insulin resulted in a -0.19% change in HbA1c with no significant difference.
- Fructosamine levels decreased by -17.5 μmol/L for post-meal walking with no significant difference.
Who this applies to
- Adults diagnosed with type 2 diabetes
- Patients managing diabetes with lifestyle interventions or insulin therapy
Keep in Mind
- Results may not apply to populations outside the study sample.
- The study's short duration limits understanding of long-term effects.
- Further research is needed to explore alternative interventions for glycemic control.
Between the Lines
- Limited sample size may affect generalizability
- Short duration of the study may not capture long-term effects
- No significant differences may indicate a need for more sensitive measures
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Insulin Therapies and HbA1c, Insulin Therapies and Fructosamine.
Related evidence relationships
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Medications
Insulin Therapies → HbA1c
Medications
Evidence Intelligence™
- EvidenceScore™
- 79
- Strong
- ImpactScore™
- 58
- Slightly Positive
- ConsistencyScore™
- 67
- generally_consistent
Supporting studies: Based on 3 studies
View evidenceMedications
Insulin Therapies → Fructosamine
Medications
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceIncluded in these evidence collections
Curated evidence collections and hubs this study is part of.
HbA1c Evidence Hub
All studies measuring HbA1c
3 studies
outcome_hubMeasures HbA1c as a key outcome.
Insulin Therapies Evidence Hub
All studies on Insulin Therapies
3 studies
intervention_hubContributes to Insulin Therapies evidence base.
Fructosamine Evidence Hub
All studies measuring Fructosamine
1 studies
outcome_hubMeasures Fructosamine as a key outcome.
Explore more in Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Basal insulin and HbA1c
Intervention: Basal insulinOutcome: HbA1c
3 results
All studies on Basal insulin and Fructosamine
Intervention: Basal insulinOutcome: Fructosamine
1 results
All studies on Basal insulin
Intervention: Basal insulin
3 results
All studies measuring HbA1c
Outcome: HbA1c
3 results
All studies measuring Fructosamine
Outcome: Fructosamine
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Insulin Therapies improve HbA1c?
Strong Evidence
Insulin Therapies may improve HbA1c.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 78.5 | weak positive | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on 13 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Basal insulin improve fructosamine?
Emerging Evidence
Basal insulin appears to improve Fructosamine.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Fructosamine
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Post-meal walking improve fructosamine?
Emerging Evidence
Post-meal walking appears to improve Fructosamine.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Fructosamine
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Post-meal walking improve HbA1c?
Emerging Evidence
Current evidence does not show a clear benefit of Post-meal walking for HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
AI Emulation Shows GLP-1 Improves HbA1c in Type 2 DiabetesHRS-7535 improves glycemic control in adults with type 2 diabetesAdding medications improves blood sugar control in diabetes patients.Combination therapy improves hepatic steatosis in T2DM patientsCombination therapy improves liver health in type 2 diabetes
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.